Evidence map›Paper›PMID 32578055›Full record

ArticleJournal of thrombosis and thrombolysis2021

Ph

Milan Košťál, Jiří Schwarz, Petra Ovesná, Miroslav Penka, Petr Dulíček, for CZEMP–Czech Group for Ph- Myeloproliferative neoplasms

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Milan KošťálUniversity Hospital Hradec Králové, Charles University, Faculty of Medicine in Hradec Králové, Hradec Králové, Czech Republic. kosmil@seznam.cz.
Jiří SchwarzInstitute of Hematology and Blood Transfusion, Prague, Czech Republic.
Petra OvesnáFaculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
Miroslav PenkaDepartment of Clinical Hematology, Faculty Hospital Brno, Masaryk University, Brno, Czech Republic.
Petr DulíčekUniversity Hospital Hradec Králové, Charles University, Faculty of Medicine in Hradec Králové, Hradec Králové, Czech Republic.
for CZEMP–Czech Group for Ph- Myeloproliferative neoplasms
Charles University · CZMasaryk University · CZUniversity Hospital Hradec Králové · CZ

Funding

Ministerstvo Zdravotnictví Ceské Republiky MH CZ - DRO (UHHK, 00179906) and PROGRES Q40/08
6 · The paper itself

Abstract

Arterial thrombosis is a common complication in patients with Ph

Indexed as

AdultAgedFemaleFibrinolytic AgentsHumansJanus Kinase 2MaleMiddle AgedMyeloproliferative DisordersQuinazolinesRisk FactorsStrokeThrombosisanagrelideFibrinolytic AgentsJAK2 protein, humanJanus Kinase 2QuinazolinesJAK2MyeloproliferationRisk factorStrokeThrombosisTIA

Identifiers

PMID32578055
OpenAlexW3036667904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.